181 related articles for article (PubMed ID: 26115039)
1. The Val30Met familial amyloid polyneuropathy specific Rasch-built overall disability scale (FAP-RODS(©) ).
Pruppers MH; Merkies IS; Faber CG; Da Silva AM; Costa V; Coelho T
J Peripher Nerv Syst; 2015 Sep; 20(3):319-27. PubMed ID: 26115039
[TBL] [Abstract][Full Text] [Related]
2. Improving assessment in small fiber neuropathy.
Brouwer BA; Bakkers M; Hoeijmakers JG; Faber CG; Merkies IS
J Peripher Nerv Syst; 2015 Sep; 20(3):333-40. PubMed ID: 26114213
[TBL] [Abstract][Full Text] [Related]
3. Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).
Binda D; Vanhoutte EK; Cavaletti G; Cornblath DR; Postma TJ; Frigeni B; Alberti P; Bruna J; Velasco R; Argyriou AA; Kalofonos HP; Psimaras D; Ricard D; Pace A; Galiè E; Briani C; Dalla Torre C; Lalisang RI; Boogerd W; Brandsma D; Koeppen S; Hense J; Storey D; Kerrigan S; Schenone A; Fabbri S; Rossi E; Valsecchi MG; Faber CG; Merkies IS; ; Galimberti S; Lanzani F; Mattavelli L; Piatti ML; Bidoli P; Cazzaniga M; Cortinovis D; Lucchetta M; Campagnolo M; Bakkers M; Brouwer B; Boogerd W; Grant R; Reni L; Piras B; Pessino A; Padua L; Granata G; Leandri M; Ghignotti I; Plasmati R; Pastorelli F; Heimans JJ; Eurelings M; Meijer RJ; Grisold W; Lindeck Pozza E; Mazzeo A; Toscano A; Russo M; Tomasello C; Altavilla G; Penas Prado M; Dominguez Gonzalez C; Dorsey SG
Eur J Cancer; 2013 Sep; 49(13):2910-8. PubMed ID: 23668917
[TBL] [Abstract][Full Text] [Related]
4. The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS).
Mul K; Hamadeh T; Horlings CGC; Tawil R; Statland JM; Sacconi S; Corbett AJ; Voermans NC; Faber CG; van Engelen BGM; Merkies ISJ
Eur J Neurol; 2021 Jul; 28(7):2339-2348. PubMed ID: 33838063
[TBL] [Abstract][Full Text] [Related]
5. Rasch-built Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS(©) ).
Vanhoutte EK; Faber CG; van Nes SI; Cats EA; Van der Pol WL; Gorson KC; van Doorn PA; Cornblath DR; van den Berg LH; Merkies IS;
J Peripher Nerv Syst; 2015 Sep; 20(3):296-305. PubMed ID: 26329270
[TBL] [Abstract][Full Text] [Related]
6. Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy.
Vinik EJ; Vinik AI; Paulson JF; Merkies IS; Packman J; Grogan DR; Coelho T
J Peripher Nerv Syst; 2014 Jun; 19(2):104-14. PubMed ID: 24738700
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area.
Takahashi R; Ono K; Shibata S; Nakamura K; Komatsu J; Ikeda Y; Ikeda T; Samuraki M; Sakai K; Iwasa K; Kayano D; Yamada M
J Neurol Sci; 2014 Oct; 345(1-2):231-5. PubMed ID: 25060417
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
Mariani LL; Lozeron P; Théaudin M; Mincheva Z; Signate A; Ducot B; Algalarrondo V; Denier C; Adam C; Nicolas G; Samuel D; Slama MS; Lacroix C; Misrahi M; Adams D;
Ann Neurol; 2015 Dec; 78(6):901-16. PubMed ID: 26369527
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic expression of familial amyloid polyneuropathy in Brazil.
Bittencourt PL; Couto CA; Clemente C; Farias AQ; Palácios SA; Mies S; Goldberg AC
Eur J Neurol; 2005 Apr; 12(4):289-93. PubMed ID: 15804246
[TBL] [Abstract][Full Text] [Related]
11. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
Ando Y; Sekijima Y; Obayashi K; Yamashita T; Ueda M; Misumi Y; Morita H; Machii K; Ohta M; Takata A; Ikeda S
J Neurol Sci; 2016 Mar; 362():266-71. PubMed ID: 26944161
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G
Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231
[TBL] [Abstract][Full Text] [Related]
13. Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Nakamura T; Hashizume A; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
J Neurol; 2017 Nov; 264(11):2293-2302. PubMed ID: 28983659
[TBL] [Abstract][Full Text] [Related]
14. Rasch-built overall disability scale for POEMS syndrome (POEMS-RODS).
Keh RYS; Lilleker JB; Lavin T; Sive J; D'Sa S; Ramdharry G; Carr AS; Lunn MP
J Peripher Nerv Syst; 2022 Dec; 27(4):302-310. PubMed ID: 36190435
[TBL] [Abstract][Full Text] [Related]
15. Circadian rhythm of blood pressure reflects the severity of cardiac impairment in familial amyloid polyneuropathy.
Algalarrondo V; Eliahou L; Thierry I; Bouzeman A; Dasoveanu M; Sebag C; Moubarak G; Le Guludec D; Samuel D; Adams D; Dinanian S; Slama MS
Arch Cardiovasc Dis; 2012 May; 105(5):281-90. PubMed ID: 22709469
[TBL] [Abstract][Full Text] [Related]
16. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P
Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395
[TBL] [Abstract][Full Text] [Related]
17. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning?
Lauro A; Diago Usò T; Masetti M; Di Benedetto F; Cautero N; De Ruvo N; Dazzi A; Quintini C; Begliomini B; Siniscalchi A; Ramacciato G; Risaliti A; Miller CM; Pinna AD
Transplant Proc; 2005 Jun; 37(5):2214-20. PubMed ID: 15964382
[TBL] [Abstract][Full Text] [Related]
19. A homozygote case of familial amyloid polyneuropathy amyloidgenic transthyretin Val30Met in a non-endemic area.
Kumabe Y; Miura A; Yamashita T; Oshima T; Misumi Y; Ueda M; Obayashi K; Horibata Y; Jono H; Ando Y; Uchino M
Amyloid; 2011 Jun; 18 Suppl 1():169-70. PubMed ID: 21838475
[No Abstract] [Full Text] [Related]
20. Postmortem findings in a familial amyloid polyneuropathy patient with homozygosity of the mutant Val30Met transthyretin gene.
Yoshinaga T; Takei Y; Katayanagi K; Ikeda S
Amyloid; 2004 Mar; 11(1):56-60. PubMed ID: 15185500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
